arrow
T

Tania Crombet

center of molecular immunology
H指数:35
被引数:4,723

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Effectiveness of Racotumomab as Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients

Racotumomab作为维持疗法在晚期非小细胞肺癌患者中的真实世界有效性

2025-10-070
OAAI
Mucosal Vaccination Against SARS-CoV-2 Using Human Probiotic Bacillus subtilis Spores as an Adjuvant Induces Potent Systemic and Mucosal Immunity

使用益生菌枯草芽孢杆菌孢子作为佐剂进行黏膜疫苗接种可诱导强效的系统性和黏膜免疫

2025-08-230
PRE
Itolizumab regulates activating and inhibitory signals on effector cells, improving their cytotoxicity against CD318+tumor cell lines

伊托利珠单抗调节效应细胞上的激活和抑制信号,增强其对CD318+肿瘤细胞系的细胞毒性。

2025-05-050
OA
PREVAX: A Phase I Clinical Trial of an EGF-Based Vaccine in Moderate-to-Severe COPD Patients
2024-07-240
OAAI
Safety and effectiveness of CIMAvax-EGF administered in community polyclinics
2024-01-184
OAAI
MACH-EGFR: Individual patient data (IPD) meta-analysis of anti-EGFR monoclonal antibodies (Ab) in patients (pts) with locally advanced (LA) squamous cell carcinomas of head and neck (SCCHN)
2023-10-010
PRE
Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC
2022-08-036
OAAI
Nimotuzumab Increases the Recovery Rate of Severe and Critical COVID-19 Patients: Evaluation in the Real-World Scenario
2022-07-222
OAAI
Association among Terminally Differentiated T Cells, Frailty, and Dependency in a Group of Cuban Centenarians

一组古巴百岁老人的终末分化T细胞,脆弱和依赖性之间的关联

2022-06-218
PRE
Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof-of-Principle Issues from a Randomized Controlled Study
2022-05-236
PRE
Thymic Polypeptide Fraction Biomodulina T Decreases Exhausted and Terminally Differentiated EMRA T Cells in Advanced Lung Cancer Patients Treated With Platinum-Based Chemotherapy

胸腺多肽组分Biomodulina T减少了接受铂类化疗的晚期肺癌患者的耗竭和终末分化EMRA T细胞

2022-01-272
OAAI